Zhejiang Shouxiangu Pharm Co (603896) — Strategic Asset Allocation Index
Zhejiang Shouxiangu Pharm Co (603896) has a Strategic Asset Allocation Index of 28.0% as of June 2023. Strategic assets (PP&E of CN¥562.91 Million plus long-term investments of CN¥-) total CN¥562.91 Million, measured against net assets of CN¥2.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Zhejiang Shouxiangu Pharm Co liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Shouxiangu Pharm Co Strategic Asset Allocation Index (2012–2022)
This chart shows how Zhejiang Shouxiangu Pharm Co's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 28.0%, representing strategic assets of CN¥562.91 Million against net assets of CN¥2.01 Billion CNY. See 603896 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Zhejiang Shouxiangu Pharm Co (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Shouxiangu Pharm Co from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zhejiang Shouxiangu Pharm Co (603896) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 31.5% | CN¥601.14 Million | CN¥601.14 Million | CN¥- | CN¥1.91 Billion | ▼ -0.3 pp |
| 2021 | 31.8% | CN¥515.91 Million | CN¥515.91 Million | CN¥- | CN¥1.62 Billion | ▲ +3.7 pp |
| 2020 | 28.2% | CN¥373.66 Million | CN¥373.66 Million | CN¥- | CN¥1.33 Billion | ▲ +1.9 pp |
| 2019 | 26.3% | CN¥308.29 Million | CN¥308.29 Million | CN¥- | CN¥1.17 Billion | ▼ -0.9 pp |
| 2018 | 27.2% | CN¥268.07 Million | CN¥268.07 Million | CN¥- | CN¥984.74 Million | ▲ +7.4 pp |
| 2017 | 19.9% | CN¥172.81 Million | CN¥172.81 Million | CN¥- | CN¥869.75 Million | ▼ -33.3 pp |
| 2016 | 53.2% | CN¥232.28 Million | CN¥232.28 Million | CN¥- | CN¥436.93 Million | ▼ -11.6 pp |
| 2015 | 64.7% | CN¥238.57 Million | CN¥238.57 Million | CN¥- | CN¥368.53 Million | ▲ +6.5 pp |
| 2014 | 58.2% | CN¥186.71 Million | CN¥186.71 Million | CN¥- | CN¥320.56 Million | ▲ +16.1 pp |
| 2013 | 42.1% | CN¥126.21 Million | CN¥126.21 Million | CN¥- | CN¥299.50 Million | ▼ -20.7 pp |
| 2012 | 62.9% | CN¥86.99 Million | CN¥86.99 Million | CN¥- | CN¥138.37 Million | — |